MedTrace Logo

Evidence-Based Medicine Electronic Decision Support Study

NCT00915304 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 12101

Last updated 2012-12-18

No results posted yet for this study

Summary

The purpose of this study is to analyze the effect of the Evidence-Based Medicine electronic Decision Support (EBMeDS) automatic reminders in primary health care.

Hypothesis (1)is that in the intervention group the total number of EBMeDS reminders will decrease compared to the control group.

Hypothesis (2) is that in the intervention group the quality measures will increase faster compared to the control group at follow-up time.

Conditions

  • Decision Support Systems, Clinical

Interventions

BEHAVIORAL

The EBMeDS reminders

Phase I: EBMeDS reminders specific to the visiting or caring patient and his/her clinical problem are generated when the practitioner uses the electronic patient record. During visits of intervention group patients the EBMeDS reminders will be shown on screen to the practitioner. Phase II: As phase I and in addition, results of the Virtual Health Check (VHC) of all the intervention group patients will be shown to the practitioners.Phase II will be fulfilled in Autumn 2010 and follow-up time will be about 3 months.

Sponsors & Collaborators

  • The Finnish Medical Society Duodecim

    collaborator UNKNOWN

  • Finnish Institute for Health and Welfare

    collaborator OTHER_GOV

  • Duodecim Medical Publications Ltd.

    collaborator INDUSTRY

  • ProWellness Ltd.

    collaborator UNKNOWN

  • The Finnish Funding Agency for Technology and Innovation (TEKES)

    collaborator OTHER_GOV

  • Tampere University

    lead OTHER

Principal Investigators

  • Pekka Rissanen, Professor · University of Tampere; School of Health Sciences

  • Tiina Kortteisto, MSc · University of Tampere; School of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00915304 on ClinicalTrials.gov